# Kanisa Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kanisa-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Total disclosed funding: $6M
- Latest round: Series B (Nov 15, 2005)
- Investors on record: 6

## About

Based in San Diego, US and founded in 2004 by David A. Socks, Kanisa Pharmaceuticals, Inc. is a pharmaceutical company which is focused on the acquisition, development and commercialisation of therapeutics in the field of oncology.

## Funding rounds

- Series B, Nov 15, 2005, $6M — InterWest Partners, New Enterprise Associates, Montreux Equity Partners, Red Abbey, CDIB BioScience Venture Management, Eli Lilly & Company

## Investors

- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B
- Montreux Equity Partners (https://capitalatlas.ai/funds/montreux-equity-partners) — Series B
- Red Abbey (https://capitalatlas.ai/funds/red-abbey) — Series B
- CDIB BioScience Venture Management (https://capitalatlas.ai/funds/cdib-bioscience-venture-management) — Series B
- Eli Lilly & Company — Series B